EMD SERONO, INC. for EMD SERONO INC
What was lobbied
12 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 4390: Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2021; all provisions of the bill H.R. 5030: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; all provisions of the bill H.R. 6000: Cures 2.0 Act; all healthcare provisions of the bill H.R. 6584: Diverse and Equitable Participation in Clinical Trials (DEPICT) Act; all provisions of the bill H.R. 6833: Affordable Insulin Now Act; provisions related to the Prescription Drug User Fee Act Reauthorization H.R. 6963: Accelerated Approval Integrity Act of 2022; all provisions of the bill H.R. 6996: Accelerating Access for Patients Act of 2022; all provisions of the bill H.R. 7667: Food and Drug Amendments of 2022; provisions related to drug development user fees S. 2706: Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act; all provisions of the bill S. 4348: Food and Drug Administration Safety and Landmark Advancements (FDASLA) Act of 2022; provisions related to drug development user fees S. 4535: Food and Drug Administration Simple Reauthorization (FDASRA) Act of 2022; provisions related to drug development user fees 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues P.L. 117-169 (H.R. 5376): Inflation Reduction Act of 2022; all provisions of the bill General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General discussions regarding drug cost and pricing policy issues General discussions related to the Cancer Moonshot Initiative and the Advanced Research Projects Agency for Health (ARPA-H) General discussion related to the Prescription Drug User Fee Act Reauthorization
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Medicare/Medicaid MMM
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 2163: Safe Step Act: all provisions of the bill H.R. 3173: Improving Seniors Timely Access to Care Act of 2021; all provisions of the bill S. 464: Safe Step Act; all provisions of the bill S.3018 - Improving Seniors Timely Access to Care Act of 2021; all provisions of the bill P.L. 117-169 (H.R. 5376): Inflation Reduction Act of 2022; all provisions of the bill 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General healthcare issues surrounding the COVID-19 pandemic
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Pharmacy PHA
H.R. 3: Elijah E. Cummings Lower Drug Costs Now Act; all provisions of the bill H.R. 2163: Safe Step Act: all provisions of the bill H.R. 3173: Improving Seniors Timely Access to Care Act of 2021; all provisions of the bill H.R. 4390: Preserving Rules Ordered for The Entities Covered Through (PROTECT) 340B Act of 2021; all provisions of the bill S. 464: Safe Step Act: all provisions of the bill S. 3108: Improving Seniors Timely Access to Care Act of 2021; all provisions of the bill P.L. 117-169 (H.R. 5376): Inflation Reduction Act of 2022; all provisions of the bill 2021 Notice of Benefit and Payment Parameters Proposed Rule - 340B Drug Pricing Program policy issues General healthcare issues surrounding the COVID-19 pandemic General issues surrounding healthcare supply chain General issues related to pharmaceutical pricing General issues related to drug development lifecycle
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Taxation/Internal Revenue Code TAX
P.L. 117-169: H.R.5376: Inflation Reduction Act of 2022 (H.R. 5376): provisions related to Inbound taxation P.L. 117-264: Further Additional Continuing Appropriations and Extensions Act, 2023 (H.R. 4373): provisions to include R & D Tax Amortization extender in Omnibus package
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Budget/Appropriations BUD
General discussion related to President Biden's FY 2022 Proposed Budget
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Science/Technology SCI
P.L. 117-167: Supreme Court Security Funding Act of 2022 (H.R. 4346 -CHIPS and Science Act of 2022): discussions regarding funding for the CHIPS and Science Act of 2022
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Economics/Economic Development ECN
General discussion of issues related to caregiving and the Healthy Women, Healthy Economies initiative
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
Family issues/Abortion/Adoption FAM
H.R.1957: Veterans Infertility Treatment Act of 2021; all provisions of the bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
Veterans VET
H.R. 7900: National Defense Authorization Act for Fiscal Year 2023; provisions related to funding infertility services at Veterans Affairs H.R. 8238: Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2023; provisions related to funding infertility services at Veterans Affairs S. 1280: Veteran Families Health Services Act of 2021; provisions related to funding infertility services at Veterans Affairs S. 4543: James M. Inhofe National Defense Authorization Act for Fiscal Year 2023; provisions related to funding infertility services at Veterans Affairs S. 4759: A bill making appropriations for military construction, the Department of Veterans Affairs, and related agencies for the fiscal year ending September 30, 2023, and for other purposes.; provisions related to funding infertility services at Veterans Affairs General discussions related to infertility treatment of the Veteran community
| Lobbyist | Covered position, as disclosed |
|---|---|
| MALLORI ANNE MERANDINO | — |
Copyright/Patent/Trademark CPT
General issues related to domestic and global intellectual property protections
| Lobbyist | Covered position, as disclosed |
|---|---|
| THOMAS BORCK | — |
| MALLORI ANNE MERANDINO | — |
| TERRI STEWART | — |
Defense DEF
H.R. 7900/S.Amd. 6442: National Defense Authorization Act for Fiscal Year 2023; provisions related to S. Amd. 6390 - Disbarment and support exclusion of the National Critical Capabilities Defense Act in the NDAA H.R. 6329/S. 1854: National Critical Capabilities Defense Act of 2021; provisions related to Outbound review mechanism
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Foreign Relations FOR
Discussions related to export controls imposed October 7, 2022 on Semiconductor industry
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHANIE FRYE (FORMERLY SALVAGNO) | — |
| PAUL JEFFREY TREADGOLD | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.